SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

By | May 12, 2022
In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs).